(Q42995407)
Statements
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy (English)
Vincenzo Pitini
Giuseppe Sturniolo
Carmela Arrigo
Silvana Leonardi
scientific article published on 8 March 2010